J&J quarterly revenue, profit edge past Street

J&J quarterly revenue, profit edge past Street
 

Johnson & Johnson (JNJ.N), the world's largest maker of healthcare products, reported third-quarter revenue and profit just ahead of Wall Street estimates, fuelled by strong sales in its prescription drugs business.
The company's net earnings rose to $4.27 billion (3.49 billion pounds), or $1.53 per share, in the third quarter, from $3.36 billion, or $1.20 per share, a year earlier.
Excluding special items, J&J earned $1.68 per share.
Revenue rose to $17.82 billion from $17.10 billion.
Analysts on average had expected a profit of $1.66 per share and revenue of $17.74 billion,... read more

 
18 October 2016 in Business, Views: 36
Source: Reuters
Share:
  •  





    News Widget for Webmasters



    Bring Eugene's son back home immediately

    Realtime News

     

    «
    »
    Mo Tu We Th Fr Sa Su
          1 2 3 4
    5 6 7 8 9 10 11
    12 13 14 15 16 17 18
    19 20 21 22 23 24 25
    26 27 28 29 30 31